Bortezomib in Anti-Cancer Activity: A Potential Drug
<p>26S proteasome is an intracellular; ATP dependent enzymatic complex degrades ubiquitin-tagged proteins and maintains cellular homeostasis. The orderly degraded proteins including cyclins, caspases, Bcl-xL, p53, cell adhesion molecules are involved in cell-cycle progression, tumor suppressio...
Saved in:
Main Authors: | Rajagopal Appavu (Author), Deepa Mohan (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Cancer Therapy - Peertechz Publications,
2016-03-08.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes.
by: Britta Stadelmann, et al.
Published: (2014) -
SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma
by: Pan Zhou, et al.
Published: (2022) -
Synthesis of a Bone-Targeted Bortezomib with In Vivo Anti-Myeloma Effects in Mice
by: Hua Wang, et al.
Published: (2018) -
Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies
by: Gül Kozalak, et al.
Published: (2023) -
Development and characterization of liposomal formulation of bortezomib
by: Anil K. Deshantri, et al.
Published: (2019)